Tapewire

Nasdaq · USD

SNES

SenesTech, Inc.

Export transactions ↓
Tapewire entity
8221
SEC CIK
0001680378
Parsed reports
222

Last 12 months

Inside the activity.

39 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202500
Jan 202610
Feb 202690
Mar 202630
Apr 202610
May 202650
Jun 2026110
Jul 202620
Aug 202630
Sep 202640
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 05, 2020 Filed Nov 25, 2020 21:44 UTC GrantStock Option (right to buy) · Derivative 27,046 $0.00 Strike: $1.41 $0.00
Disclosure

SEC source: 0001225208-20-013965 · doc4.xml · derivative · entry 1

Leach Jacob Steven · CIK 0001700255 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,046

Underlying: Common Stock · 27,046 shares

Expires 2025-11-05

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total shares on the first day of each calendar quarter following the date of grant provided that any portion remaining unvested as of June 30, 2021 will vest as of such date (subject to recipient's continued service to the Company through such vesting date).

Read SEC document
July 31, 2020 Filed Aug 3, 2020 18:02 UTC
SIEGEL KENNETH SDirector · CEO
GrantStock Option (right to buy) · Derivative 101,965 $0.00 Strike: $1.80 $0.00
Disclosure

SEC source: 0001225208-20-010171 · doc4.xml · derivative · entry 1

SIEGEL KENNETH S · CIK 0001167024 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,965

Underlying: Common Stock · 101,965 shares

Expires 2025-07-31

F1 · derivative.exercise_date: Date at which first vesting occurs is indicated. 1/12th of the total stock option granted vests on the first vesting date and an additional 1/12th will vest on the last day of each quarter thereafter, with 100% of the stock option fully vested on 6-30-2023.

Read SEC document
July 31, 2020 Filed Aug 3, 2020 22:03 UTC
CHESTERMAN THOMAS CCFO & Treasurer
GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $1.80 $0.00
Disclosure

SEC source: 0001225208-20-010172 · doc4.xml · derivative · entry 1

CHESTERMAN THOMAS C · CIK 0001247660 · CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2025-07-31

F1 · derivative.exercise_date: Date at which first vesting occurs is indicated. 1/12th of the total stock option granted vests on the first vesting date and an additional 1/12th will vest on the last day of each quarter thereafter, with 100% of the stock option fully vested on 6-30-2023.

Read SEC document
July 24, 2020 Filed Jul 27, 2020 19:52 UTC
Wolin Kim PatriceEVP & Secretary
GrantRestricted Stock Units · Derivative 30,738 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009984 · doc4.xml · derivative · entry 1

Wolin Kim Patrice · CIK 0001689616 · EVP & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,738

Underlying: Common Stock · 30,738 shares

Expires not disclosed

F1 · derivative.exercise_price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of April 29, 2021 or recipients termination of employment.

F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of April 29, 2021 or recipients termination of employment.

Read SEC document
July 24, 2020 Filed Jul 27, 2020 23:52 UTC GrantStock Option (right to buy) · Derivative 2,921 $0.00 Strike: $1.97 $0.00
Disclosure

SEC source: 0001225208-20-009985 · doc4.xml · derivative · entry 1

Morrison Jamie Bechtel · CIK 0001729595 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,921

Underlying: Common Stock · 2,921 shares

Expires 2025-07-24

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total shares on the first day of each calendar quarter following the date of grant provided that any portion remaining unvested as of the one-year anniversary of the date of grant will vest as of such date (subject to recipient's continued service to the Company through such vesting dates).

Read SEC document
July 10, 2020 Filed Jul 15, 2020 11:46 UTC
DUMONT MARCDirector
GrantStock Option (right to buy) · Derivative 24,098 $0.00 Strike: $1.97 $0.00
Disclosure

SEC source: 0001225208-20-009749 · doc4.xml · derivative · entry 1

DUMONT MARC · CIK 0001030600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,098

Underlying: Common Stock · 24,098 shares

Expires 2025-07-10

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total shares on the first day of each calendar quarter following the date of grant provided that any portion remaining unvested as of the one-year anniversary of the date of grant will vest as of such date (subject to recipient's continued service to the Company through such vesting dates).

Read SEC document
July 10, 2020 Filed Jul 15, 2020 11:46 UTC GrantStock Option (right to buy) · Derivative 21,177 $0.00 Strike: $1.97 $0.00
Disclosure

SEC source: 0001225208-20-009751 · doc4.xml · derivative · entry 1

Williams Julia Ann · CIK 0001689618 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,177

Underlying: Common Stock · 21,177 shares

Expires 2025-07-10

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total shares on the first day of each calendar quarter following the date of grant provided that any portion remaining unvested as of the one-year anniversary of the date of grant will vest as of such date (subject to recipient's continued service to the Company through such vesting dates).

Read SEC document
July 10, 2020 Filed Jul 15, 2020 15:46 UTC GrantStock Option (right to buy) · Derivative 31,401 $0.00 Strike: $1.97 $0.00
Disclosure

SEC source: 0001225208-20-009750 · doc4.xml · derivative · entry 1

Szot Matthew K · CIK 0001401385 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,401

Underlying: Common Stock · 31,401 shares

Expires 2025-07-10

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total shares on the first day of each calendar quarter following the date of grant provided that any portion remaining unvested as of the one-year anniversary of the date of grant will vest as of such date (subject to recipient's continued service to the Company through such vesting dates).

Read SEC document
July 10, 2020 Filed Jul 15, 2020 15:46 UTC GrantStock Option (right to buy) · Derivative 28,480 $0.00 Strike: $1.97 $0.00
Disclosure

SEC source: 0001225208-20-009748 · doc4.xml · derivative · entry 1

Chiavarini Delphine Francois · CIK 0001744264 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,480

Underlying: Common Stock · 28,480 shares

Expires 2025-07-10

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total shares on the first day of each calendar quarter following the date of grant provided that any portion remaining unvested as of the one-year anniversary of the date of grant will vest as of such date (subject to recipient's continued service to the Company through such vesting dates).

Read SEC document
July 10, 2020 Filed Jul 15, 2020 15:46 UTC GrantStock Option (right to buy) · Derivative 40,164 $0.00 Strike: $1.97 $0.00
Disclosure

SEC source: 0001225208-20-009747 · doc4.xml · derivative · entry 1

Morrison Jamie Bechtel · CIK 0001729595 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,164

Underlying: Common Stock · 40,164 shares

Expires 2025-07-10

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total shares on the first day of each calendar quarter following the date of grant provided that any portion remaining unvested as of the one-year anniversary of the date of grant will vest as of such date (subject to recipient's continued service to the Company through such vesting dates).

Read SEC document
June 18, 2020 Filed Jun 22, 2020 21:25 UTC
DUMONT MARCDirector
Exercise / conversionRestricted Stock Units · Derivative 564 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009146 · doc4.xml · derivative · entry 4

DUMONT MARC · CIK 0001030600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 564 shares

Expires 2020-06-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F1 · shares: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F3 · derivative.exercise_date: The restricted stock units vest in full on the earlier of the date of the Company's 2020 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

F3 · derivative.expiration_date: The restricted stock units vest in full on the earlier of the date of the Company's 2020 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

F1 · derivative.underlying_shares: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Read SEC document
June 18, 2020 Filed Jun 22, 2020 21:25 UTC
DUMONT MARCDirector
Exercise / conversionCommon Stock 564 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009146 · doc4.xml · nonDerivative · entry 1

DUMONT MARC · CIK 0001030600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,337

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F2 · price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F1 · balance_after: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Read SEC document
June 18, 2020 Filed Jun 22, 2020 21:35 UTC Exercise / conversionRestricted Stock Units · Derivative 423 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009149 · doc4.xml · derivative · entry 5

Williams Julia Ann · CIK 0001689618 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 423 shares

Expires 2020-06-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F1 · shares: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F5 · derivative.exercise_date: The restricted stock units vest in full on the earlier of the date of the Company's 2020 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

F5 · derivative.expiration_date: The restricted stock units vest in full on the earlier of the date of the Company's 2020 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

F1 · derivative.underlying_shares: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Read SEC document
June 18, 2020 Filed Jun 22, 2020 21:35 UTC Exercise / conversionCommon Stock 423 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009149 · doc4.xml · nonDerivative · entry 1

Williams Julia Ann · CIK 0001689618 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Julia A. Williams MD Trust

Disclosed balance after: 8,161.95

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F2 · price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F1 · balance_after: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Read SEC document
June 18, 2020 Filed Jun 23, 2020 01:25 UTC Exercise / conversionRestricted Stock Units · Derivative 846 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009147 · doc4.xml · derivative · entry 2

Szot Matthew K · CIK 0001401385 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 846 shares

Expires 2020-06-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F1 · shares: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F3 · derivative.exercise_date: The restricted stock units vest in full on the earlier of the date of the Company's 2020 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

F3 · derivative.expiration_date: The restricted stock units vest in full on the earlier of the date of the Company's 2020 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

F1 · derivative.underlying_shares: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Read SEC document
June 18, 2020 Filed Jun 23, 2020 01:25 UTC Exercise / conversionCommon Stock 846 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009147 · doc4.xml · nonDerivative · entry 1

Szot Matthew K · CIK 0001401385 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Szot Family Trust

Disclosed balance after: 4,658

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F2 · price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F1 · balance_after: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Read SEC document
June 18, 2020 Filed Jun 23, 2020 01:36 UTC Exercise / conversionRestricted Stock Units · Derivative 846 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009150 · doc4.xml · derivative · entry 2

Chiavarini Delphine Francois · CIK 0001744264 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 846 shares

Expires 2020-06-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F1 · shares: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F3 · derivative.exercise_date: The restricted stock units vest in full on the earlier of the date of the Company's 2020 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

F3 · derivative.expiration_date: The restricted stock units vest in full on the earlier of the date of the Company's 2020 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

F1 · derivative.underlying_shares: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Read SEC document
June 18, 2020 Filed Jun 23, 2020 01:36 UTC Exercise / conversionCommon Stock 846 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009150 · doc4.xml · nonDerivative · entry 1

Chiavarini Delphine Francois · CIK 0001744264 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,314

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F2 · price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F1 · balance_after: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Read SEC document
June 18, 2020 Filed Jun 23, 2020 01:25 UTC Exercise / conversionRestricted Stock Units · Derivative 1,198 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009145 · doc4.xml · derivative · entry 2

Morrison Jamie Bechtel · CIK 0001729595 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,198 shares

Expires 2020-06-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F1 · shares: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F3 · derivative.exercise_date: The restricted stock units vest in full on the earlier of the date of the Company's 2020 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

F3 · derivative.expiration_date: The restricted stock units vest in full on the earlier of the date of the Company's 2020 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

F1 · derivative.underlying_shares: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Read SEC document
June 18, 2020 Filed Jun 23, 2020 01:25 UTC Exercise / conversionCommon Stock 1,198 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009145 · doc4.xml · nonDerivative · entry 1

Morrison Jamie Bechtel · CIK 0001729595 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,812

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F2 · price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F1 · balance_after: On February 4, 2020, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Read SEC document
April 28, 2020 Filed Apr 30, 2020 18:10 UTC
Krause Steven C.EVP, Sales and Marketing
GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $2.44 $0.00
Disclosure

SEC source: 0001225208-20-006925 · doc4.xml · derivative · entry 1

Krause Steven C. · CIK 0001810605 · EVP, Sales and Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2025-04-28

F1 · derivative.exercise_date: The option vests and becomes exercisable as to 1/36th of the total shares on each monthly anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting dates).

Read SEC document
October 21, 2019 Filed Oct 22, 2019 19:40 UTC
Mayer Loretta PowersDirector · Chief Scientific Officer
SaleCommon Stock 6,000 $0.83 $4,980.00
Disclosure

SEC source: 0001225208-19-013766 · doc4.xml · nonDerivative · entry 2

Mayer Loretta Powers · CIK 0001689608 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 335,165

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 5, 2017.

Read SEC document
October 02, 2019 Filed Oct 4, 2019 17:14 UTC
Dyer Cheryl AnnPres. & Chief Research Officer
GiftCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-013206 · doc4.xml · nonDerivative · entry 2

Dyer Cheryl Ann · CIK 0001689556 · Pres. & Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 320,091

Read SEC document
October 02, 2019 Filed Oct 4, 2019 17:14 UTC
Dyer Cheryl AnnPres. & Chief Research Officer
SaleCommon Stock 6,000 $0.93 $5,574.60
Disclosure

SEC source: 0001225208-19-013206 · doc4.xml · nonDerivative · entry 1

Dyer Cheryl Ann · CIK 0001689556 · Pres. & Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 370,091

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person July 5, 2017.

F2 · price: The price shown is a weighted average sales price. The shares were sold at prices ranging from $0.90 to $0.97 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
September 20, 2019 Filed Sep 27, 2019 17:41 UTC
Wolin Kim PatriceEVP & Secretary
GrantStock Option (right to buy) · Derivative 40,000 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001225208-19-012804 · doc4.xml · derivative · entry 1

Wolin Kim Patrice · CIK 0001689616 · EVP & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2024-09-20

F1 · derivative.exercise_date: Date at which first vesting occurs is indicated. One-twelfth of the total stock options granted vest on the first vesting date and quarterly thereafter over three years of continuous service.

Read SEC document
September 20, 2019 Filed Sep 27, 2019 21:41 UTC
CHESTERMAN THOMAS CCFO & Treasurer
GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001225208-19-012803 · doc4.xml · derivative · entry 1

CHESTERMAN THOMAS C · CIK 0001247660 · CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2024-09-20

F1 · derivative.exercise_date: Date at which first vesting occurs is indicated. One-twelfth of the total stock options granted vest on the first vesting date and quarterly thereafter over three years of continuous service.

Read SEC document
August 27, 2019 Filed Oct 22, 2019 19:40 UTC
Mayer Loretta PowersDirector · Chief Scientific Officer
GiftCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-013766 · doc4.xml · nonDerivative · entry 1

Mayer Loretta Powers · CIK 0001689608 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 341,165

Read SEC document
August 15, 2019 Filed Aug 16, 2019 17:46 UTC
Mayer Loretta PowersDirector · Chief Scientific Officer
SaleCommon Stock 20,000 $1.19 $23,734.00
Disclosure

SEC source: 0001225208-19-011640 · doc4.xml · nonDerivative · entry 2

Mayer Loretta Powers · CIK 0001689608 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 371,165

F2 · price: The price shown is a weighted average sales price. The shares were sold at prices ranging from $1.18 to $1.23 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 15, 2019 Filed Aug 16, 2019 17:46 UTC
Dyer Cheryl AnnPres. & Chief Research Officer
SaleCommon Stock 20,000 $1.21 $24,100.00
Disclosure

SEC source: 0001225208-19-011641 · doc4.xml · nonDerivative · entry 2

Dyer Cheryl Ann · CIK 0001689556 · Pres. & Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 376,091

F2 · price: The price shown is a weighted average sales price. The shares were sold at prices ranging from $1.18 to $1.23 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 14, 2019 Filed Aug 16, 2019 17:46 UTC
Mayer Loretta PowersDirector · Chief Scientific Officer
SaleCommon Stock 20,000 $1.24 $24,756.00
Disclosure

SEC source: 0001225208-19-011640 · doc4.xml · nonDerivative · entry 1

Mayer Loretta Powers · CIK 0001689608 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 391,165

F1 · price: The price shown is a weighted average sales price. The shares were sold at prices ranging from $1.20 to $1.27 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
August 14, 2019 Filed Aug 16, 2019 17:46 UTC
Dyer Cheryl AnnPres. & Chief Research Officer
SaleCommon Stock 20,000 $1.18 $23,622.00
Disclosure

SEC source: 0001225208-19-011641 · doc4.xml · nonDerivative · entry 1

Dyer Cheryl Ann · CIK 0001689556 · Pres. & Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 396,091

F1 · price: The price shown is a weighted average sales price. The shares were sold at prices ranging from $1.16 to $1.22 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
July 16, 2019 Filed Jul 18, 2019 17:48 UTC
SIEGEL KENNETH SDirector · CEO
PurchaseCommon Stock 696,296 $1.35 $939,999.60
Disclosure

SEC source: 0001225208-19-010368 · doc4.xml · nonDerivative · entry 1

SIEGEL KENNETH S · CIK 0001167024 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 702,558

Read SEC document
June 30, 2019 Filed Jul 2, 2019 17:51 UTC
Mayer Loretta PowersDirector · Chief Scientific Officer
Exercise / conversionRestricted Stock Units · Derivative 18,336 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-19-009922 · doc4.xml · derivative · entry 4

Mayer Loretta Powers · CIK 0001689608 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,336 shares

Expires 2019-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F2 · derivative.exercise_date: Date at which first vesting occured is indicated. One-third of the total restricted stock units ("RSUs") granted vested on the first vesting date and the remaining RSUs vested in equal quarterly tranches over the next 24 months of continuous service.

F3 · derivative.expiration_date: Date at which final vesting occured is indicated.

Read SEC document
June 30, 2019 Filed Jul 2, 2019 17:51 UTC
Mayer Loretta PowersDirector · Chief Scientific Officer
Tax withholdingCommon Stock 8,543 $1.80 $15,377.40
Disclosure

SEC source: 0001225208-19-009922 · doc4.xml · nonDerivative · entry 2

Mayer Loretta Powers · CIK 0001689608 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 411,165

Read SEC document
June 30, 2019 Filed Jul 2, 2019 17:51 UTC
Mayer Loretta PowersDirector · Chief Scientific Officer
Exercise / conversionCommon Stock 18,336 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-009922 · doc4.xml · nonDerivative · entry 1

Mayer Loretta Powers · CIK 0001689608 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,708

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

Read SEC document
June 30, 2019 Filed Jul 2, 2019 17:51 UTC
Dyer Cheryl AnnPres. & Chief Research Officer
Exercise / conversionRestricted Stock Units · Derivative 18,336 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-19-009921 · doc4.xml · derivative · entry 4

Dyer Cheryl Ann · CIK 0001689556 · Pres. & Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,336 shares

Expires 2019-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F2 · derivative.exercise_date: Date at which first vesting occured is indicated. One-third of the total restricted stock units ("RSUs") granted vested on the first vesting date and the remaining RSUs vested in equal quarterly tranches over the next 24 months of continuous service.

F3 · derivative.expiration_date: Date at which final vesting occured is indicated.

Read SEC document
June 30, 2019 Filed Jul 2, 2019 17:51 UTC
Dyer Cheryl AnnPres. & Chief Research Officer
Tax withholdingCommon Stock 8,871 $1.80 $15,967.80
Disclosure

SEC source: 0001225208-19-009921 · doc4.xml · nonDerivative · entry 2

Dyer Cheryl Ann · CIK 0001689556 · Pres. & Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 416,091

Read SEC document
June 30, 2019 Filed Jul 2, 2019 17:51 UTC
Dyer Cheryl AnnPres. & Chief Research Officer
Exercise / conversionCommon Stock 18,336 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-009921 · doc4.xml · nonDerivative · entry 1

Dyer Cheryl Ann · CIK 0001689556 · Pres. & Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 424,962

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:13 UTC
DUMONT MARCDirector
GrantStock Option (right to buy) · Derivative 22,896 $0.00 Strike: $1.42 $0.00
Disclosure

SEC source: 0001225208-19-009484 · doc4.xml · derivative · entry 6

DUMONT MARC · CIK 0001030600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,896

Underlying: Common Stock · 22,896 shares

Expires 2024-06-18

F4 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total shares on the first day of each calendar quarter following the date of grant provided that any portion remaining unvested as of the one-year anniversary of the date of grant will vest as of such date (subject to recipient's continued service to the Company through such vesting dates).

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:13 UTC
DUMONT MARCDirector
GrantRestricted Stock Units · Derivative 11,268 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-009484 · doc4.xml · derivative · entry 5

DUMONT MARC · CIK 0001030600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,268

Underlying: Common Stock · 11,268 shares

Expires 2020-06-18

F1 · derivative.exercise_price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in full on the earlier of the date of the Company's 2020 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

F3 · derivative.expiration_date: The restricted stock units vest in full on the earlier of the date of the Company's 2020 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:13 UTC
DUMONT MARCDirector
Exercise / conversionRestricted Stock Units · Derivative 8,791 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-009484 · doc4.xml · derivative · entry 4

DUMONT MARC · CIK 0001030600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,791 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of the date of the Company's 2019 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of the date of the Company's 2019 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:13 UTC
DUMONT MARCDirector
Exercise / conversionCommon Stock 8,791 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-009484 · doc4.xml · nonDerivative · entry 1

DUMONT MARC · CIK 0001030600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,454

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:13 UTC
SIEGEL KENNETH SDirector · CEO
Exercise / conversionRestricted Stock Units · Derivative 6,262 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-19-009482 · doc4.xml · derivative · entry 2

SIEGEL KENNETH S · CIK 0001167024 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,262 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of the date of the Company's 2019 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of the date of the Company's 2019 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:13 UTC
SIEGEL KENNETH SDirector · CEO
Exercise / conversionCommon Stock 6,262 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-009482 · doc4.xml · nonDerivative · entry 1

SIEGEL KENNETH S · CIK 0001167024 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,262

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:13 UTC GrantStock Option (right to buy) · Derivative 18,535 $0.00 Strike: $1.42 $0.00
Disclosure

SEC source: 0001225208-19-009487 · doc4.xml · derivative · entry 7

Williams Julia Ann · CIK 0001689618 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,535

Underlying: Common Stock · 18,535 shares

Expires 2024-06-18

F6 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total shares on the first day of each calendar quarter following the date of grant provided that any portion remaining unvested as of the one-year anniversary of the date of grant will vest as of such date (subject to recipient's continued service to the Company through such vesting dates).

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:13 UTC GrantRestricted Stock Units · Derivative 8,451 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-009487 · doc4.xml · derivative · entry 6

Williams Julia Ann · CIK 0001689618 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,451

Underlying: Common Stock · 8,451 shares

Expires 2020-06-18

F1 · derivative.exercise_price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F5 · derivative.exercise_date: The restricted stock units vest in full on the earlier of the date of the Company's 2020 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

F5 · derivative.expiration_date: The restricted stock units vest in full on the earlier of the date of the Company's 2020 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:13 UTC Exercise / conversionRestricted Stock Units · Derivative 7,692 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-009487 · doc4.xml · derivative · entry 5

Williams Julia Ann · CIK 0001689618 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,692 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F4 · derivative.exercise_date: The restricted stock units vest in full on the earlier of the date of the Company's 2019 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

F4 · derivative.expiration_date: The restricted stock units vest in full on the earlier of the date of the Company's 2019 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

Read SEC document
June 18, 2019 Filed Jun 20, 2019 20:13 UTC Exercise / conversionCommon Stock 7,692 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-009487 · doc4.xml · nonDerivative · entry 1

Williams Julia Ann · CIK 0001689618 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Julia A. Williams MD Trust

Disclosed balance after: 154,779

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

Read SEC document
June 18, 2019 Filed Jun 21, 2019 00:13 UTC GrantStock Option (right to buy) · Derivative 31,618 $0.00 Strike: $1.42 $0.00
Disclosure

SEC source: 0001225208-19-009486 · doc4.xml · derivative · entry 4

Szot Matthew K · CIK 0001401385 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,618

Underlying: Common Stock · 31,618 shares

Expires 2024-06-18

F4 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total shares on the first day of each calendar quarter following the date of grant provided that any portion remaining unvested as of the one-year anniversary of the date of grant will vest as of such date (subject to recipient's continued service to the Company through such vesting dates).

Read SEC document
June 18, 2019 Filed Jun 21, 2019 00:13 UTC GrantRestricted Stock Units · Derivative 16,901 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-009486 · doc4.xml · derivative · entry 3

Szot Matthew K · CIK 0001401385 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,901

Underlying: Common Stock · 16,901 shares

Expires 2020-06-18

F1 · derivative.exercise_price: The restricted stock units are settled for shares of common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in full on the earlier of the date of the Company's 2020 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

F3 · derivative.expiration_date: The restricted stock units vest in full on the earlier of the date of the Company's 2020 annual stockholder meeting, or the one-year anniversary of the date of grant (subject to recipient's continued service to the Company through such vesting date).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.